XORTX Therapeutics Inc (XRTX)
2.91
-0.03
(-1.02%)
USD |
NASDAQ |
Apr 24, 16:00
2.91
0.00 (0.00%)
After-Hours: 19:25
XORTX Therapeutics Shareholders Equity (Quarterly): 6.086M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 6.086M |
| June 30, 2023 | 7.398M |
| March 31, 2023 | 9.059M |
| December 31, 2022 | 6.975M |
| September 30, 2022 | 7.829M |
| June 30, 2022 | 9.502M |
| March 31, 2022 | 10.73M |
| December 31, 2021 | 13.13M |
| September 30, 2021 | -3.323M |
| June 30, 2021 | 2.678M |
| March 31, 2021 | 2.750M |
| December 31, 2020 | 0.9852M |
| September 30, 2020 | 1.248M |
| June 30, 2020 | 1.468M |
| March 31, 2020 | 1.543M |
| December 31, 2019 | -0.1621M |
| September 30, 2019 | -0.0762M |
| June 30, 2019 | 0.0157M |
| March 31, 2019 | 0.1216M |
| Date | Value |
|---|---|
| December 31, 2018 | 0.2361M |
| September 30, 2018 | 0.3563M |
| June 30, 2018 | 0.5689M |
| March 31, 2018 | 0.7729M |
| December 31, 2017 | -0.5206M |
| November 30, 2017 | 0.0328M |
| September 30, 2017 | -0.3467M |
| August 31, 2017 | 0.0491M |
| May 31, 2017 | 0.0963M |
| February 28, 2017 | 0.1344M |
| November 30, 2016 | 0.3331M |
| August 31, 2016 | 0.1307M |
| May 31, 2016 | 0.1711M |
| February 29, 2016 | 0.1973M |
| November 30, 2015 | 0.2302M |
| August 31, 2015 | 0.0446M |
| May 31, 2015 | 0.085M |
| February 28, 2015 | 0.0959M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-3.323M
Minimum
Sep 2021
13.13M
Maximum
Dec 2021
4.324M
Average
2.714M
Median
Shareholders Equity (Quarterly) Benchmarks
| ImmunoPrecise Antibodies Ltd | 37.62M |
| Acasti Pharma Inc | 64.68M |
| Aurinia Pharmaceuticals Inc | 377.95M |
| Edesa Biotech Inc | 5.845M |
| Lexaria Bioscience Corp | 6.521M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.640M |
| Total Liabilities (Quarterly) | 0.5538M |